285 related articles for article (PubMed ID: 15705897)
1. Silencing of CXCR4 blocks breast cancer metastasis.
Liang Z; Yoon Y; Votaw J; Goodman MM; Williams L; Shim H
Cancer Res; 2005 Feb; 65(3):967-71. PubMed ID: 15705897
[TBL] [Abstract][Full Text] [Related]
2. [Chemokine receptor CXCR4 gene silencing with shRNA inhibits breast cancer metastasis to the lung in nude mice].
Zhang MX; Han N; Yu SY; Leng Y
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):325-9. PubMed ID: 18953828
[TBL] [Abstract][Full Text] [Related]
3. CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo.
Lapteva N; Yang AG; Sanders DE; Strube RW; Chen SY
Cancer Gene Ther; 2005 Jan; 12(1):84-9. PubMed ID: 15472715
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro.
Chen Y; Stamatoyannopoulos G; Song CZ
Cancer Res; 2003 Aug; 63(16):4801-4. PubMed ID: 12941798
[TBL] [Abstract][Full Text] [Related]
5. [The effects of shRNA-CXCR4 on breast cancer cells migration and invasion].
Li HY; Ren GS; Tan JX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):393-7. PubMed ID: 19626989
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of CXCR4-siRNA by scFv for HER2(+) breast cancer therapy.
Jiang K; Li J; Yin J; Ma Q; Yan B; Zhang X; Wang L; Wang L; Liu T; Zhang Y; Fan Q; Yang A; Qiu X; Ma B
Biomaterials; 2015 Aug; 59():77-87. PubMed ID: 25956853
[TBL] [Abstract][Full Text] [Related]
7. [Effect of small interfering RNA targeting CXCR4 on breast cancer angiogenesis].
Li HY; Ren GS; Tan JX
Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):954-8. PubMed ID: 19460719
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells.
Wendt MK; Cooper AN; Dwinell MB
Oncogene; 2008 Feb; 27(10):1461-71. PubMed ID: 17724466
[TBL] [Abstract][Full Text] [Related]
9. [The effects of CXCR4 inhibited by RNA interference on metastasis and invasion of breast cancer cell in vitro].
Zhang SC; Qiao L; Gao H
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):473-5. PubMed ID: 17686306
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4.
Liang Z; Wu T; Lou H; Yu X; Taichman RS; Lau SK; Nie S; Umbreit J; Shim H
Cancer Res; 2004 Jun; 64(12):4302-8. PubMed ID: 15205345
[TBL] [Abstract][Full Text] [Related]
11. Anticancer effects of chemokine receptor 4(CXCR4) gene silenced by CXCR4-siRNA in nude mice model of ovarian cancer.
Liu W; Wang Y; Wang H; Wang A
Cell Biochem Biophys; 2014 Dec; 70(3):1893-900. PubMed ID: 25149650
[TBL] [Abstract][Full Text] [Related]
12. Increased Survival by Pulmonary Treatment of Established Lung Metastases with Dual STAT3/CXCR4 Inhibition by siRNA Nanoemulsions.
Li Z; Chen G; Ding L; Wang Y; Zhu C; Wang K; Li J; Sun M; Oupicky D
Mol Ther; 2019 Dec; 27(12):2100-2110. PubMed ID: 31481310
[TBL] [Abstract][Full Text] [Related]
13. Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA.
Liang Z; Wu H; Reddy S; Zhu A; Wang S; Blevins D; Yoon Y; Zhang Y; Shim H
Biochem Biophys Res Commun; 2007 Nov; 363(3):542-6. PubMed ID: 17889832
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of CXCR4 significantly contributes to metastasis and predicts poor clinical outcome in breast cancer.
Yang P; Liang SX; Huang WH; Zhang HW; Li XL; Xie LH; Du CW; Zhang GJ
Curr Mol Med; 2014 Jan; 14(1):174-84. PubMed ID: 24256053
[TBL] [Abstract][Full Text] [Related]
15. Reversibly Stabilized Polycation Nanoparticles for Combination Treatment of Early- and Late-Stage Metastatic Breast Cancer.
Chen G; Wang Y; Wu P; Zhou Y; Yu F; Zhu C; Li Z; Hang Y; Wang K; Li J; Sun M; Oupicky D
ACS Nano; 2018 Jul; 12(7):6620-6636. PubMed ID: 29985577
[TBL] [Abstract][Full Text] [Related]
16. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
Guo B; Zhang Y; Luo G; Li L; Zhang J
Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of breast cancer cell growth and invasiveness by dual silencing of HER-2 and VEGF.
Tai W; Qin B; Cheng K
Mol Pharm; 2010 Apr; 7(2):543-56. PubMed ID: 20047302
[TBL] [Abstract][Full Text] [Related]
18. Deletion of Yin Yang 1 protein in osteosarcoma cells on cell invasion and CXCR4/angiogenesis and metastasis.
de Nigris F; Rossiello R; Schiano C; Arra C; Williams-Ignarro S; Barbieri A; Lanza A; Balestrieri A; Giuliano MT; Ignarro LJ; Napoli C
Cancer Res; 2008 Mar; 68(6):1797-808. PubMed ID: 18339860
[TBL] [Abstract][Full Text] [Related]
19. Baohuoside I suppresses invasion of cervical and breast cancer cells through the downregulation of CXCR4 chemokine receptor expression.
Kim B; Park B
Biochemistry; 2014 Dec; 53(48):7562-9. PubMed ID: 25407882
[TBL] [Abstract][Full Text] [Related]
20. In vivo knockdown of CXCR4 using jetPEI/CXCR4 shRNA nanoparticles inhibits the pulmonary metastatic potential of B16‑F10 melanoma cells.
André ND; Silva VA; Ariza CB; Watanabe MA; De Lucca FL
Mol Med Rep; 2015 Dec; 12(6):8320-6. PubMed ID: 26498029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
